ML20236E564
| ML20236E564 | |
| Person / Time | |
|---|---|
| Issue date: | 06/12/1989 |
| From: | Carr K NRC COMMISSION (OCM) |
| To: | William Allen, Croft B AMERICAN COLLEGE OF NUCLEAR PHYSICIANS, SOCIETY OF NUCLEAR MEDICINE |
| Shared Package | |
| ML20236E567 | List: |
| References | |
| FRN-54FR38239, RULE-PR-35-9, RULE-PRM-35-9 NUDOCS 8906210276 | |
| Download: ML20236E564 (1) | |
Text
E
-- = z
.-.m
~
{, lL
/
UNhhbini.TN o
.@% 'm ^ n i G! FAR REGULATORY COMMISSION h.
3 i
WAgndO'M D. C. 20555 e
June 12, 1989 CHAIRMAN E. William Allen, M,0.,
Presiden~t American College of Nuclear Physicians Barbara Y. Croft, Ph.D., President Society of Nuclear Medicine 1101 Connecticut Avenue, N.W.,
Suite 700 l
Washington, D.C.
20036
Dear Drs. Allen and Croft:
I have received your letter of May 19, 1989, in which you commentea on the Nuclear Regulatory Commission's (NRC's) 1987 revisions to 10 CFR Part 35 and indicated your intention to file a petition for rulemaking with respect to the preparation and use of radiopharmaceuticals for diagnostic and therapeutic purposes.
Our April 1987 revision of 10 CFR Part 35
" Medical Use of l
l Byproduct Material," was undertaken to clarify and concriiuase NRC's radiation safety requirements iGr the ;;c cf oyproduct material for medical care.
Our goal is to ensure that the risks associated with the use of byproduct material are as low as reasonably achievable.
~
l The NRC staf f will review your petition for rulemaking and provide its recommendations on an appropriate course of action to the Commission.
We assure you that your views will be carefully considered in reaching a determination on whether additional rulemaking is needed.
If the Commission decides to proceed with rulemaking, the NRC staff will work with the Food and Drug Administration to coordinase proposed regulation of radio-pharmaceutical use.
Any such proposal would, of course, be l
published for public comme ~nt.
Sincerely, aw%.%J Kenneth M. Carr Acting Chairman 0F91 8906210276 890612
(
PDR COMMS NRCC CORRESPONDENCE PDC
-